A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
EBCTCG Analysis Identifies Recurrence Risk by Tumor Subgroup in Estrogen Receptor–Positive Breast Cancer - The ASCO Post
Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect
Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning - ScienceDirect
Cumulative incidence of breast cancer recurrence according to age... | Download Scientific Diagram
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Breast Cancer Survival Rates: Prognosis by Age, Race & More
Breast Cancer Metastasis : Survival Rates for Stage IV
Breast Cancer Local Recurrence Risk Calculator
New Model Predicts Impact of Post-Mastectomy Radiation on Breast Cancer Survival – Consult QD
Breast cancer: Stage, receptor status help determine recurrence risk
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy | PLOS ONE
The risk of contralateral breast cancer: a SEER-based analysis | British Journal of Cancer
Magee Equations
Online Breast Calculators
What to Expect From the Results - Breast Recurrence Score® Test | Precision Oncology
Breast Cancer Prognosis
CRIB
Breast Cancer Prognosis
Breast Cancer Index™ Prognostic Validation For Risk Of Late Distant Recurrence
Breast Cancer Risk Calculator - Fight Like a Girl! 🎀
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence | Scientific Reports
New Online App May Help Doctors Predict Risk of Breast Cancer Recurrence - 10/10/2016
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years | NEJM
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years | NEJM
Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
